10/16/2025
4:16 PM | Iterum Therapeutics (Filer)
| Form 424B5 | |
10/16/2025
4:18 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2025
3:15 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2025
3:30 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2025
7:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2025
6:00 AM | Dunne Michael W. (Reporting)
Iterum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2025
6:30 AM | Iterum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2025
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2025
4:00 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2025
7:00 AM | Iterum Therapeutics (Filer)
| Form PRE 14A | |
07/03/2025
3:15 PM | Coyne Christine (Reporting)
Iterum Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for ITRM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Iterum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
07/03/2025
3:16 PM | Coyne Christine (Reporting)
Iterum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/19/2025
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2025
6:30 AM | Iterum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2025
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2025
8:11 PM | Iterum Therapeutics (Filer)
| Form 424B5 | |
04/29/2025
8:16 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2025
7:00 AM | Iterum Therapeutics (Issuer)
Whalen Joseph John (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/10/2025
7:35 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2025
11:15 PM | Iterum Therapeutics (Filer)
| Form EFFECT | |
02/14/2025
4:36 PM | ARMISTICE CAPITAL, LLC (Filed by)
Iterum Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/07/2025
3:33 PM | Iterum Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/07/2025
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
6:30 AM | Iterum Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/23/2025
5:30 PM | HUNT RONALD (Reporting)
Iterum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
5:30 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2024
6:04 AM | Iterum Therapeutics (Filer)
| Form 424B5 | |
11/21/2024
8:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
6:54 PM | Iterum Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
6:30 AM | Iterum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/14/2024
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
4:10 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
5:24 AM | Iterum Therapeutics (Filer)
| Form 424B5 | |
10/28/2024
5:06 AM | Iterum Therapeutics (Filer)
| Form 424B5 | |
10/25/2024
10:20 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
